BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35503891)

  • 21. Distinct genomic features in a retrospective cohort of mucosal, acral, and vulvovaginal melanomas.
    Shi K; Zhang B; Kong BY; Zhang Y; Igartua C; Mohan LS; Quan VL; Panah E; Isales MC; Beaubier N; Taxter TJ; White KP; Zou L; Gerami P
    J Am Acad Dermatol; 2023 May; 88(5):1051-1059. PubMed ID: 31306728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatic activation of KIT in distinct subtypes of melanoma.
    Curtin JA; Busam K; Pinkel D; Bastian BC
    J Clin Oncol; 2006 Sep; 24(26):4340-6. PubMed ID: 16908931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BRAF, NRAS, KIT, TERT, GNAQ/GNA11 mutation profile analysis of head and neck mucosal melanomas: a study of 42 cases.
    Öztürk Sari Ş; Yilmaz İ; Taşkin OÇ; Narli G; Şen F; Çomoğlu Ş; Firat P; Bİlgİç B; Yilmazbayhan D; Özlük Y; Büyükbabanİ N
    Pathology; 2017 Jan; 49(1):55-61. PubMed ID: 27914687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases.
    Lyu J; Wu Y; Li C; Wang R; Song H; Ren G; Guo W
    J Oral Pathol Med; 2016 Apr; 45(4):295-301. PubMed ID: 26399561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutational status of naevus-associated melanomas.
    Shitara D; Tell-Martí G; Badenas C; Enokihara MM; Alós L; Larque AB; Michalany N; Puig-Butille JA; Carrera C; Malvehy J; Puig S; Bagatin E
    Br J Dermatol; 2015 Sep; 173(3):671-80. PubMed ID: 25857817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral, and lentigo maligna subtypes.
    Lang J; MacKie RM
    J Invest Dermatol; 2005 Sep; 125(3):575-9. PubMed ID: 16117801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].
    Lázár V
    Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRAF V600 mutations and pathological features in Japanese melanoma patients.
    Yamazaki N; Tanaka R; Tsutsumida A; Namikawa K; Eguchi H; Omata W; Oashi K; Ogawa T; Hayashi A; Nakamura N; Tsuta K
    Melanoma Res; 2015 Feb; 25(1):9-14. PubMed ID: 25051202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma.
    Siroy AE; Boland GM; Milton DR; Roszik J; Frankian S; Malke J; Haydu L; Prieto VG; Tetzlaff M; Ivan D; Wang WL; Torres-Cabala C; Curry J; Roy-Chowdhuri S; Broaddus R; Rashid A; Stewart J; Gershenwald JE; Amaria RN; Patel SP; Papadopoulos NE; Bedikian A; Hwu WJ; Hwu P; Diab A; Woodman SE; Aldape KD; Luthra R; Patel KP; Shaw KR; Mills GB; Mendelsohn J; Meric-Bernstam F; Kim KB; Routbort MJ; Lazar AJ; Davies MA
    J Invest Dermatol; 2015 Feb; 135(2):508-515. PubMed ID: 25148578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution and clinical role of KIT gene mutations in melanoma according to subtype: a study of 492 Spanish patients.
    Millán-Esteban D; García-Casado Z; Manrique-Silva E; Virós A; Kumar R; Furney S; López-Guerrero JA; Requena C; Bañuls J; Traves V; Nagore E
    Eur J Dermatol; 2021 Dec; 31(6):830-838. PubMed ID: 33648909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRAF and NRAS mutations in melanoma and melanocytic nevi.
    Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
    Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent KRAS, KIT and SF3B1 mutations in melanoma of the female genital tract.
    Cai YJ; Ke LF; Zhang WW; Lu JP; Chen YP
    BMC Cancer; 2021 Jun; 21(1):677. PubMed ID: 34102999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in the BRAF, NRAS, and C-KIT Genes of Patients Diagnosed with Melanoma in Colombia Population.
    Gutiérrez-Castañeda LD; Gamboa M; Nova JA; Pulido L; Tovar-Parra JD
    Biomed Res Int; 2020; 2020():2046947. PubMed ID: 32775409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
    Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
    Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of anaplastic lymphoma kinase break points and oncogenic mutation profiles in acral/mucosal melanomas.
    Niu HT; Zhou QM; Wang F; Shao Q; Guan YX; Wen XZ; Chen LZ; Feng QS; Li W; Zeng YX; Zhang XS
    Pigment Cell Melanoma Res; 2013 Sep; 26(5):646-53. PubMed ID: 23751074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct sets of genetic alterations in melanoma.
    Curtin JA; Fridlyand J; Kageshita T; Patel HN; Busam KJ; Kutzner H; Cho KH; Aiba S; Bröcker EB; LeBoit PE; Pinkel D; Bastian BC
    N Engl J Med; 2005 Nov; 353(20):2135-47. PubMed ID: 16291983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High frequency of PTEN mutations in nevi and melanomas from xeroderma pigmentosum patients.
    Masaki T; Wang Y; DiGiovanna JJ; Khan SG; Raffeld M; Beltaifa S; Hornyak TJ; Darling TN; Lee CC; Kraemer KH
    Pigment Cell Melanoma Res; 2014 May; 27(3):454-64. PubMed ID: 24483290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BRAF, KIT and NRAS mutations and expression of c-KIT, phosphorylated extracellular signal-regulated kinase and phosphorylated AKT in Japanese melanoma patients.
    Oyama S; Funasaka Y; Watanabe A; Takizawa T; Kawana S; Saeki H
    J Dermatol; 2015 May; 42(5):477-84. PubMed ID: 25766129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal melanoma: clinical, histological and c-kit gene mutational profile of 86 French cases.
    Cinotti E; Chevallier J; Labeille B; Cambazard F; Thomas L; Balme B; Leccia MT; D'Incan M; Vercherin P; Douchet C; Rubegni P; Perrot JL
    J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1834-1840. PubMed ID: 28543798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRAF, NRAS and KIT sequencing analysis of spindle cell melanoma.
    Kim J; Lazar AJ; Davies MA; Homsi J; Papadopoulos NE; Hwu WJ; Bedikian AY; Woodman SE; Patel SP; Hwu P; Kim KB
    J Cutan Pathol; 2012 Sep; 39(9):821-5. PubMed ID: 22809251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.